Impact of social determinants of health on esketamine nasal spray initiation among patients with treatment-resistant depression in the United States
Disparities in esketamine nasal spray initiation were observed based on education, income, and gender highlighting a potential health equity gap.
Authors
- Arthur Voegel
- Maryia Zhdanava (ORCID: https://orcid.org/0000-0002-7995-2578)
- Amanda Teeple
- Kristin K. Clemens (ORCID: https://orcid.org/0000-0001-9636-5597)
- Kruti Joshi (ORCID: https://orcid.org/0000-0001-9263-5158)
- Aditi Shah
- Dominic Pilon (ORCID: https://orcid.org/0000-0002-6093-7167)
- Cindy Chen (ORCID: https://orcid.org/0000-0002-5358-7349)
Institutions
- Johnson & Johnson (United States) (US)
- Group for Research in Decision Analysis (CA)
- Janssen (United States) (US)
- Janssen Scientific Affairs (United States)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2024-12-20
- DOI
- https://doi.org/10.18553/jmcp.2025.24240
- Citations
- 3
- Primary Topic
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Janssen Scientific Affairs